Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP627301.RADtZ2NN4g4QgLrUSVbfH--hcgURtQflQhBX62Dzd_XrE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP627301.RADtZ2NN4g4QgLrUSVbfH--hcgURtQflQhBX62Dzd_XrE130_assertion type Assertion NP627301.RADtZ2NN4g4QgLrUSVbfH--hcgURtQflQhBX62Dzd_XrE130_head.
- NP627301.RADtZ2NN4g4QgLrUSVbfH--hcgURtQflQhBX62Dzd_XrE130_assertion description "[These cases demonstrate that oral sulfonylurea may be the treatment of choice in PND patients with KCNJ11 mutations even at a young age.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP627301.RADtZ2NN4g4QgLrUSVbfH--hcgURtQflQhBX62Dzd_XrE130_provenance.
- NP627301.RADtZ2NN4g4QgLrUSVbfH--hcgURtQflQhBX62Dzd_XrE130_assertion evidence source_evidence_literature NP627301.RADtZ2NN4g4QgLrUSVbfH--hcgURtQflQhBX62Dzd_XrE130_provenance.
- NP627301.RADtZ2NN4g4QgLrUSVbfH--hcgURtQflQhBX62Dzd_XrE130_assertion SIO_000772 17728498 NP627301.RADtZ2NN4g4QgLrUSVbfH--hcgURtQflQhBX62Dzd_XrE130_provenance.
- NP627301.RADtZ2NN4g4QgLrUSVbfH--hcgURtQflQhBX62Dzd_XrE130_assertion wasDerivedFrom befree-2016 NP627301.RADtZ2NN4g4QgLrUSVbfH--hcgURtQflQhBX62Dzd_XrE130_provenance.
- NP627301.RADtZ2NN4g4QgLrUSVbfH--hcgURtQflQhBX62Dzd_XrE130_assertion wasGeneratedBy ECO_0000203 NP627301.RADtZ2NN4g4QgLrUSVbfH--hcgURtQflQhBX62Dzd_XrE130_provenance.